Young boy dies in trial for Pfizer Duchenne gene therapy
Related Articles
-
Pfizer reports death of young boy with DMD who participated in gene therapy trial
A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7
-
Pfizer Stock Hit After Boy Dies Of Cardiac Arrest During Gene Therapy Trial
Pfizer Stock Hit After Boy Dies Of Cardiac Arrest During Gene Therapy Trial Stock in Pfizer dropped on Tuesday after a young boy receiving experimental gene therapy for Duchenne muscular dystrophy died during the trial. According to STAT News, Pfizer has yet to determine exactly what happened or how the boy died Pfizer has confirmed that the boy suffered cardiac arrest, and is pausing crossing over patients in its randomized phase 3 trial of the treatment in older boys, according...
-
Pfizer pauses trial for experimental gene therapy drug after child participant dies suddenly
The boy, who was aged between two and four, suffered a cardiac arrest after receiving the one-off gene therapy last year. It was poised to become one of the world's most expensive drugs.